Is the opioid crisis a national emergency?
Commission issues interim report with numerous calls to action, while manufacturers and distributors contend with multiple DEA penalties
It’s time for an industry guideline on patient support services
A conversation with Greg Flynn, Ashfield Healthcare US
LogiPharma meeting highlights digital transformation
Supply chain leaders gather in Philadelphia in October
Drug development in rare diseases
‘Right to try’ programs see renewed legislative attention
PDUFA reauthorization creates new pathways; GAO report notes FDA’s 99% acceptance rate for expanded access
HDA’s fourth international conference heads to Geneva
Global supply chain issues in distribution bring senior execs together
Change is a constant for sales incentive planning
Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions
New approaches to specialty distribution
A direct-distribution model could save expense for payers and patients while providing better service
GE Healthcare offers an automated device for cell thawing
A better way to reverse the cryopreservation common in cellular therapies
PCI adds to cold chain capacity in Philadelphia
A 60% increase in pallet storage capability
MMIS MediSpend chooses LexisNexis for agg spend reporting
Master data on prescribers is combined with tracking expenditures, for transparency reporting
Opioid drug deaths continued steep climb in 2016, says preliminary CDC data
An estimated 64,070 deaths recorded; meanwhile, private equity flows into addiction centers
FDA approves Novartis’ CAR-T therapy for leukemia, ushering in the gene therapy era
First gene therapy product in US; approval expedited by evidence of high cure rates
Gilead-Kite Pharma deal reverberates through cell-therapy field
Investors hope for a repeat of Gilead’s Sovaldi success
ODA-designation application to approval in 19 days for Curtana Pharmaceuticals
Company is targeting a treatment for glioblastoma; Phase I to begin next year
The under-regulated world of patient services
Pharma needs better internal policies to manage its increasing patient interaction
Tune up your suspicious order monitoring programs, says QuintilesIMS
In the midst of the opioid crisis, drug distributors need to address DEA oversight
Mylan finalizes a DoJ settlement over EpiPen pricing
Observers are critical of the $465-million penalty as too lenient
PRA Health Sciences acquires Symphony Health Solutions, scrip and prescriber data provider
Leading CRO looks to better trial recruitment, outcomes research
Post-approval trials of new drugs are showing limited clinical value
Is the accelerated-approval process providing a net benefit to patients?
Sonoco ThermoSafe offers affordable reusable containers
Specialized conditioning technology simplifies the shipment prep work
Cold chain vendors enhance product and service lines
CEIV Pharma certification; expanded temperature regimes and better calibration capabilities
Merck CEO, Kenneth Frazier, leaves Trump manufacturing council
A protest against not protesting; unclear consequences for pharma’s place on the White House council
CVS readies a set of outcomes-based contracts for its clients
Oncology, obesity control and respiratory therapy are the first targets
EMA entertains relocation bids, readies a business-continuity plan
New location, following Brexit, will be decided in November
Life Science Logistics expands warehouse capacity, again
Firm has quintupled its Indianapolis facility over two years
rfXcel gets a $30-million private equity boost
Pharma traceability company will expand global presence
Opioid crisis commission issues interim report with numerous calls to action
Meanwhile, opioid manufacturers and distributors contend with multiple DEA penalties
TraceLink acquires Roc IT, a serialization ‘edge solutions’ provider
Action better integrates warehouse operations into pharma traceability
